Vincerx Pharma Files Q1 2025 10-Q
Ticker: VINC · Form: 10-Q · Filed: May 15, 2025 · CIK: 1796129
| Field | Detail |
|---|---|
| Company | Vincerx Pharma, Inc. (VINC) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-reporting
Related Tickers: VINC
TL;DR
Vincerx Pharma (VINC) filed its Q1 2025 10-Q. Check financials.
AI Summary
Vincerx Pharma, Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as LifeSci Acquisition Corp. and Vincera Pharma, Inc., is involved in the pharmaceutical preparations industry. The filing includes financial data for the first quarter of 2025 and the preceding fiscal year.
Why It Matters
This filing provides investors with an update on Vincerx Pharma's financial performance and position as of the end of the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Vincerx Pharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (This is the end date for the financial reporting period covered by the 10-Q.)
- 2024-12-31 — Previous Year End Date (Provides a comparison point for financial performance.)
- 2024-03-31 — Prior Year Q1 End Date (Allows for year-over-year quarterly comparison.)
Key Players & Entities
- Vincerx Pharma, Inc. (company) — Filer
- LifeSci Acquisition Corp. (company) — Former company name
- Vincera Pharma, Inc. (company) — Former company name
- 20250331 (date) — Conformed period of report
- 20250515 (date) — Filed as of date
FAQ
What is Vincerx Pharma's primary business activity?
Vincerx Pharma, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was Vincerx Pharma previously known by other names?
The company was formerly known as Vincera Pharma, Inc. (name change effective 20201223) and LifeSci Acquisition Corp. (name change effective 20191206).
What is the filing date of this 10-Q?
This 10-Q was filed as of May 15, 2025.
What period does this 10-Q report on?
This 10-Q reports on the period ending March 31, 2025.
What is the company's business address?
The business address is 260 Sheridan Avenue, Suite 400, Palo Alto, CA 94306.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Vincerx Pharma, Inc. (VINC).